Shares of Viking Therapeutics (VKTX-0.86%) have already risen more than four-fold this year. Despite Viking's rapid ascent Oppenheimer analyst, Jay Olson thinks it can climb much higher over the ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

The Viking 74 had a blazing act to follow in replacing the Viking 72, the fastest ride in the six-decade history of the company. The 72 Convertible ran 45 knots and racked up 75 sales, the number ...

Viking Therapeutics Inc. (NASDAQ: VKTX), a clinical-stage biotechnology company with a market cap approaching $7 billion, is turning heads in 2024. Year to date, the stock has surged an impressive 238 ...

Mixing a spread of artificial lures and natural baits can offer greater flexibility in your trolling strategy. ©️Scott Kerrigan/www.aquapaparazzi.com “It was the second day of the Big Rock tournament ...

Viking Therapeutics Inc.’s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the competitive bar for ...

Viking Ashanti (ASX: VKA) is well on its way to securing a package of advanced thermal and coking coal assets in Mongolia after receiving 75.72% acceptances ...

Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst April 01, 2024 — 01:49 pm EDT Written by Cory Renauer for The Motley Fool -> ...